학술논문

Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases.
Document Type
Article
Source
Science Translational Medicine; 1/5/2022, Vol. 14 Issue 626, p1-16, 16p
Subject
Language
ISSN
19466234